Correlation Between SIMCERE PHARMAC and Evotec SE

Can any of the company-specific risk be diversified away by investing in both SIMCERE PHARMAC and Evotec SE at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SIMCERE PHARMAC and Evotec SE into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between SIMCERE PHARMAC GRP and Evotec SE, you can compare the effects of market volatilities on SIMCERE PHARMAC and Evotec SE and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SIMCERE PHARMAC with a short position of Evotec SE. Check out your portfolio center. Please also check ongoing floating volatility patterns of SIMCERE PHARMAC and Evotec SE.

Diversification Opportunities for SIMCERE PHARMAC and Evotec SE

0.57

Correlation Coefficient

SIMCERE PHARMAC  Evotec SE

Very weak diversification

The 3 months correlation between SIMCERE and Evotec is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding SIMCERE PHARMAC GRP and Evotec SE in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Evotec SE and SIMCERE PHARMAC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SIMCERE PHARMAC GRP are associated (or correlated) with Evotec SE. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Evotec SE has no effect on the direction of SIMCERE PHARMAC i.e., SIMCERE PHARMAC and Evotec SE go up and down completely randomly.

Pair Corralation between SIMCERE PHARMAC and Evotec SE

Assuming the 90 days horizon SIMCERE PHARMAC GRP is expected to generate 0.74 times more return on investment than Evotec SE. However, SIMCERE PHARMAC GRP is 1.34 times less risky than Evotec SE. It trades about 0.02 of its potential returns per unit of risk. Evotec SE is currently generating about -0.02 per unit of risk. If you would invest  78.00  in SIMCERE PHARMAC GRP on September 26, 2024 and sell it today you would earn a total of  3.00  from holding SIMCERE PHARMAC GRP or generate 3.85% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

SIMCERE PHARMAC GRP  vs.  Evotec SE

SIMCERE PHARMAC GRP

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in SIMCERE PHARMAC GRP are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain basic indicators, SIMCERE PHARMAC reported solid returns over the last few months and may actually be approaching a breakup point.

Evotec SE

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Evotec SE are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Evotec SE unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with SIMCERE PHARMAC and Evotec SE

The main advantage of trading using opposite SIMCERE PHARMAC and Evotec SE positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SIMCERE PHARMAC position performs unexpectedly, Evotec SE can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evotec SE will offset losses from the drop in Evotec SE's long position.

The idea behind SIMCERE PHARMAC GRP and Evotec SE pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.